U.S. flag

An official website of the United States government

NM_001165963.4(SCN1A):c.3776T>C (p.Phe1259Ser) AND Early infantile epileptic encephalopathy with suppression bursts

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 12, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000701047.15

Allele description [Variation Report for NM_001165963.4(SCN1A):c.3776T>C (p.Phe1259Ser)]

NM_001165963.4(SCN1A):c.3776T>C (p.Phe1259Ser)

Genes:
SCN1A:sodium voltage-gated channel alpha subunit 1 [Gene - OMIM - HGNC]
LOC102724058:uncharacterized LOC102724058 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
2q24.3
Genomic location:
Preferred name:
NM_001165963.4(SCN1A):c.3776T>C (p.Phe1259Ser)
Other names:
p.F1259S:TTC>TCC
HGVS:
  • NC_000002.12:g.166012212A>G
  • NG_011906.1:g.66428T>C
  • NM_001165963.4:c.3776T>CMANE SELECT
  • NM_001165963.4:c.3776T>C
  • NM_001165964.3:c.3692T>C
  • NM_001202435.3:c.3776T>C
  • NM_001353948.2:c.3776T>C
  • NM_001353949.2:c.3743T>C
  • NM_001353950.2:c.3743T>C
  • NM_001353951.2:c.3743T>C
  • NM_001353952.2:c.3743T>C
  • NM_001353954.2:c.3740T>C
  • NM_001353955.2:c.3740T>C
  • NM_001353957.2:c.3692T>C
  • NM_001353958.2:c.3692T>C
  • NM_001353960.2:c.3689T>C
  • NM_001353961.2:c.1334T>C
  • NM_006920.6:c.3743T>C
  • NP_001159435.1:p.Phe1259Ser
  • NP_001159436.1:p.Phe1231Ser
  • NP_001189364.1:p.Phe1259Ser
  • NP_001340877.1:p.Phe1259Ser
  • NP_001340878.1:p.Phe1248Ser
  • NP_001340879.1:p.Phe1248Ser
  • NP_001340880.1:p.Phe1248Ser
  • NP_001340881.1:p.Phe1248Ser
  • NP_001340883.1:p.Phe1247Ser
  • NP_001340884.1:p.Phe1247Ser
  • NP_001340886.1:p.Phe1231Ser
  • NP_001340887.1:p.Phe1231Ser
  • NP_001340889.1:p.Phe1230Ser
  • NP_001340890.1:p.Phe445Ser
  • NP_008851.3:p.Phe1248Ser
  • LRG_8:g.66428T>C
  • NC_000002.11:g.166868722A>G
  • NC_000002.11:g.166868722A>G
  • NM_001165963.1:c.3776T>C
  • NR_148667.2:n.4129T>C
Protein change:
F1230S
Links:
dbSNP: rs398123591
NCBI 1000 Genomes Browser:
rs398123591
Molecular consequence:
  • NM_001165963.4:c.3776T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001165964.3:c.3692T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001202435.3:c.3776T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353948.2:c.3776T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353949.2:c.3743T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353950.2:c.3743T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353951.2:c.3743T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353952.2:c.3743T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353954.2:c.3740T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353955.2:c.3740T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353957.2:c.3692T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353958.2:c.3692T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353960.2:c.3689T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353961.2:c.1334T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006920.6:c.3743T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_148667.2:n.4129T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Early infantile epileptic encephalopathy with suppression bursts (EIEE)
Synonyms:
Early infantile epileptic encephalopathy; Ohtahara syndrome; Developmental and epileptic encephalopathy
Identifiers:
MONDO: MONDO:0100062; MedGen: C0393706; Orphanet: 1934; OMIM: PS308350

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000829829Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jan 12, 2024)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.

Lindy AS, Stosser MB, Butler E, Downtain-Pickersgill C, Shanmugham A, Retterer K, Brandt T, Richard G, McKnight DA.

Epilepsia. 2018 May;59(5):1062-1071. doi: 10.1111/epi.14074. Epub 2018 Apr 14.

PubMed [citation]
PMID:
29655203

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Invitae, SCV000829829.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (2)

Description

This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 1259 of the SCN1A protein (p.Phe1259Ser). This variant is present in population databases (rs398123591, gnomAD 0.0009%). This missense change has been observed in individuals with clinical features of SCN1A-related conditions (PMID: 29655203; Invitae). ClinVar contains an entry for this variant (Variation ID: 93645). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN1A protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 6, 2024